Loading data for LNSR — first visit, this takes a few seconds.
LENSAR, Inc. (LNSR)
NasdaqCM: LNSR
· Real-Time Price · USD
8.58
+0.33 (4.00%)
At close: Sep 08, 2026, 5:59 PM
The price, the headline numbers and the latest news, in one place.
LENSAR, Inc. (LNSR) Stock Price, Analysis & Data
No data available
| Bid | 6.07 |
| Market Cap | 106M |
| Revenue (ttm) | 60.3M |
| Net Income (ttm) | 14.7M |
| 0.97 | |
| 0.2 | |
| 42.95 | |
| -12.1 | |
| P/B (ttm) | 7.08 |
| P/S (ttm) | 1.75 |
| Earnings Date | Nov 12, 2026 |
| Ask | 10.61 |
| Volume | 113,273 |
| Avg. Volume (20D) | 122,566 |
| Open | 8.26 |
| Previous Close | 8.25 |
| Day's Range | 8.26 - 8.72 |
| 52-Week Range | 4.95 - 12.94 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About LNSR
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual out...
Industry Medical Devices
Sector Healthcare
IPO Date Oct 2, 2020
Employees 150
Stock Exchange NasdaqCM
Ticker Symbol LNSR
Website https://www.lensar.com
Financial Performance
In 2025, LENSAR's revenue was 58.44M, an increase of 9.24% compared to the previous year's 53.49M. Earnings were -34.28M, an increase of 9.16%.
Financial StatementsEarnings Surprise
LENSAR has released their quarterly earnings on Aug 13, 2026:
- Revenue of $16.5M misses estimates by $0, with 18.37% YoY growth.
- EPS of 0.1 exceeds estimates by 0.37, with 200.00% YoY growth.
LENSAR, Inc. is scheduled to release its earnings on Nov 12, 2026, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2